These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion. Santos RD; Lorenzatti A; Corral P; Nogueira JP; Cafferata AM; Aimone D; Lourenço CM; Izar MC; Lima JG; Lottenberg AM; Alonso R; Garay K; Morales AR; Vargas-Uricoechea H; Peña CAC; Roman-González A J Clin Lipidol; 2021; 15(5):620-624. PubMed ID: 34920815 [TBL] [Abstract][Full Text] [Related]
25. Familial chylomicronemia syndrome: The first case reported in Ecuador. Garay García KJ; Chong Menendez RJ; Nogueira JP; Piedra Andrade JS Clin Investig Arterioscler; 2022; 34(6):326-329. PubMed ID: 36184299 [TBL] [Abstract][Full Text] [Related]
26. Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome. Zhang Y; Zhou J; Zheng W; Lan Z; Huang Z; Yang Q; Liu C; Gao R; Zhang Y Lipids Health Dis; 2016 May; 15():88. PubMed ID: 27153815 [TBL] [Abstract][Full Text] [Related]
27. Familial Chylomicronemia Syndrome With a Novel Homozygous LPL Mutation Identified in Three Siblings in Their 50s. Ueda M; Burke FM; Remaley AT; Hegele RA; Rader DJ; Dunbar RL Ann Intern Med; 2020 Apr; 172(7):500-502. PubMed ID: 31739313 [No Abstract] [Full Text] [Related]
28. Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia - Case Report and Literature Review. Cao C; Liu Y; Liu L; Wang X J Atheroscler Thromb; 2024 Jul; 31(7):1106-1111. PubMed ID: 38462482 [TBL] [Abstract][Full Text] [Related]
29. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report. Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710 [TBL] [Abstract][Full Text] [Related]
31. Novel pathogenic variant combination in Shi H; Wang Z Transl Pediatr; 2022 Oct; 11(10):1717-1725. PubMed ID: 36345447 [TBL] [Abstract][Full Text] [Related]
32. Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome. Marco-Benedí V; Lamiquiz-Moneo I; Álvarez-Sala LA; Civeira F Atherosclerosis; 2018 Aug; 275():342-345. PubMed ID: 30015297 [TBL] [Abstract][Full Text] [Related]
33. Etiology and emerging treatments for familial chylomicronemia syndrome. Spagnuolo CM; Hegele RA Expert Rev Endocrinol Metab; 2024 Jul; 19(4):299-306. PubMed ID: 38866702 [TBL] [Abstract][Full Text] [Related]
34. Familial chylomicronemia syndrome caused by compound heterozygous mutation of lipoprotein lipase gene: A case report and review of literature. Huang Y; Qin Y; Liao L; Lin F Clin Chim Acta; 2022 Dec; 537():112-117. PubMed ID: 36252692 [TBL] [Abstract][Full Text] [Related]
35. Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention. Wilson LM; Cross RR; Duell PB J Clin Lipidol; 2018; 12(1):240-242. PubMed ID: 29195809 [TBL] [Abstract][Full Text] [Related]
36. Targeting APOC3 in the familial chylomicronemia syndrome. Gaudet D; Brisson D; Tremblay K; Alexander VJ; Singleton W; Hughes SG; Geary RS; Baker BF; Graham MJ; Crooke RM; Witztum JL N Engl J Med; 2014 Dec; 371(23):2200-6. PubMed ID: 25470695 [TBL] [Abstract][Full Text] [Related]
37. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054 [TBL] [Abstract][Full Text] [Related]
38. The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency. Steinhagen-Thiessen E; Stroes E; Soran H; Johnson C; Moulin P; Iotti G; Zibellini M; Ossenkoppele B; Dippel M; Averna MR; Atherosclerosis; 2017 Jul; 262():146-153. PubMed ID: 28284702 [TBL] [Abstract][Full Text] [Related]
39. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis. Chyzhyk V; Brown AS Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756 [TBL] [Abstract][Full Text] [Related]
40. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study. Davidson M; Stevenson M; Hsieh A; Ahmad Z; Roeters van Lennep J; Crowson C; Witztum JL J Clin Lipidol; 2018; 12(4):898-907.e2. PubMed ID: 29784572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]